Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application of the Microculture Kinetic (MiCK) Assay for Apoptosis to Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas

NCT00443196 is registered in ClinicalTrials.gov with Pierian Biosciences as lead sponsor.

NCT NCT00443196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00443196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application of the Microculture Kinetic (MiCK) Assay for Apoptosis to Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas
Lead sponsor
Pierian Biosciences
Phase
Phase 2/3
Overall status
Completed
Start date
March 31, 2006
Completion date
September 30, 2010
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma, fallopian tube neoplasms, ovarian neoplasms, peritoneal neoplasms